Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bromocriptine | 5 | 2022 | 111 | 1.850 |
Why?
|
| Dopamine Agonists | 4 | 2017 | 355 | 1.480 |
Why?
|
| Metformin | 6 | 2018 | 836 | 0.910 |
Why?
|
| Diet, Sodium-Restricted | 4 | 2012 | 287 | 0.700 |
Why?
|
| Hypoglycemic Agents | 6 | 2017 | 2873 | 0.700 |
Why?
|
| Sodium Chloride, Dietary | 4 | 2013 | 281 | 0.520 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2022 | 11726 | 0.450 |
Why?
|
| Parathyroid Neoplasms | 2 | 2011 | 245 | 0.440 |
Why?
|
| Renin-Angiotensin System | 3 | 2012 | 758 | 0.420 |
Why?
|
| Hypertension | 9 | 2013 | 8479 | 0.410 |
Why?
|
| Hyperglycemia | 3 | 2015 | 1373 | 0.400 |
Why?
|
| Angiotensin II | 2 | 2011 | 881 | 0.370 |
Why?
|
| Renin | 5 | 2012 | 642 | 0.350 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2011 | 160 | 0.340 |
Why?
|
| Insulin | 6 | 2017 | 6582 | 0.330 |
Why?
|
| Sodium, Dietary | 3 | 2012 | 418 | 0.330 |
Why?
|
| Prediabetic State | 1 | 2013 | 499 | 0.310 |
Why?
|
| Glipizide | 3 | 2018 | 47 | 0.310 |
Why?
|
| Hypopituitarism | 1 | 2010 | 254 | 0.310 |
Why?
|
| Pancreatitis | 2 | 2011 | 1092 | 0.300 |
Why?
|
| Interleukin-6 | 2 | 2011 | 3203 | 0.250 |
Why?
|
| Adenoma | 2 | 2011 | 2174 | 0.230 |
Why?
|
| Blood Glucose | 10 | 2018 | 6254 | 0.220 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 15160 | 0.210 |
Why?
|
| Oxidoreductases, N-Demethylating | 2 | 2012 | 115 | 0.200 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 1345 | 0.200 |
Why?
|
| Pregnancy Complications | 2 | 2011 | 2861 | 0.190 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2018 | 154 | 0.180 |
Why?
|
| Heart Transplantation | 1 | 2013 | 3112 | 0.180 |
Why?
|
| Hydrocortisone | 2 | 2012 | 1826 | 0.180 |
Why?
|
| Histone Demethylases | 2 | 2012 | 321 | 0.170 |
Why?
|
| Norepinephrine | 2 | 2013 | 909 | 0.170 |
Why?
|
| Hypercalcemia | 2 | 2011 | 409 | 0.160 |
Why?
|
| Double-Blind Method | 3 | 2017 | 12025 | 0.160 |
Why?
|
| Insulin Resistance | 4 | 2017 | 3864 | 0.150 |
Why?
|
| Incretins | 1 | 2018 | 88 | 0.150 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 6489 | 0.140 |
Why?
|
| Blood Pressure | 6 | 2013 | 8551 | 0.140 |
Why?
|
| Sulfonylurea Compounds | 1 | 2018 | 205 | 0.140 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15535 | 0.130 |
Why?
|
| Syncope | 1 | 1997 | 429 | 0.120 |
Why?
|
| Amyloidosis | 2 | 1998 | 796 | 0.120 |
Why?
|
| Amino Acids, Aromatic | 1 | 2013 | 32 | 0.120 |
Why?
|
| Mineralocorticoids | 1 | 2012 | 38 | 0.110 |
Why?
|
| Middle Aged | 20 | 2018 | 213390 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 2 | 2014 | 1877 | 0.100 |
Why?
|
| Hypertension, Renal | 1 | 2012 | 177 | 0.100 |
Why?
|
| Diabetes Mellitus | 3 | 2015 | 5749 | 0.100 |
Why?
|
| Delayed-Action Preparations | 1 | 2015 | 968 | 0.100 |
Why?
|
| Inflammation | 1 | 2011 | 10637 | 0.100 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2012 | 164 | 0.100 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2013 | 251 | 0.100 |
Why?
|
| Pharmacogenetics | 1 | 2015 | 674 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2018 | 15520 | 0.090 |
Why?
|
| Hemodynamics | 2 | 2011 | 4196 | 0.090 |
Why?
|
| Polyuria | 1 | 2010 | 39 | 0.090 |
Why?
|
| Female | 25 | 2018 | 380193 | 0.090 |
Why?
|
| Epinephrine | 1 | 2013 | 792 | 0.090 |
Why?
|
| Hyperparathyroidism | 1 | 2011 | 339 | 0.090 |
Why?
|
| Xerostomia | 1 | 2010 | 95 | 0.090 |
Why?
|
| Heart Failure | 1 | 2013 | 10895 | 0.090 |
Why?
|
| Anorexia | 1 | 2010 | 161 | 0.090 |
Why?
|
| Diabetes Insipidus | 1 | 2010 | 151 | 0.090 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 638 | 0.080 |
Why?
|
| Cardiomyopathies | 2 | 1998 | 1912 | 0.080 |
Why?
|
| Diet | 1 | 2007 | 7937 | 0.080 |
Why?
|
| Adult | 18 | 2018 | 214052 | 0.080 |
Why?
|
| Lymphatic Diseases | 1 | 2010 | 323 | 0.080 |
Why?
|
| Glucose Tolerance Test | 3 | 2018 | 1151 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2017 | 63107 | 0.080 |
Why?
|
| Male | 21 | 2018 | 350115 | 0.080 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 834 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 493 | 0.070 |
Why?
|
| Humans | 29 | 2022 | 744366 | 0.070 |
Why?
|
| Low Back Pain | 2 | 2011 | 956 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.070 |
Why?
|
| Triglycerides | 1 | 2013 | 2453 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12961 | 0.060 |
Why?
|
| Environment | 1 | 2011 | 1123 | 0.060 |
Why?
|
| Aged | 10 | 2018 | 163288 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2010 | 1851 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2011 | 1064 | 0.060 |
Why?
|
| Glucocorticoids | 2 | 2012 | 2108 | 0.060 |
Why?
|
| Normetanephrine | 1 | 2022 | 26 | 0.060 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2022 | 46 | 0.050 |
Why?
|
| Sympatholytics | 1 | 2022 | 83 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 20824 | 0.050 |
Why?
|
| L-Selectin | 1 | 2022 | 214 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 2924 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2022 | 249 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12244 | 0.050 |
Why?
|
| Phenotype | 5 | 2022 | 16367 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2013 | 4397 | 0.050 |
Why?
|
| Prolactin | 1 | 2022 | 669 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2007 | 2634 | 0.050 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2022 | 354 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5867 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2010 | 2417 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2013 | 40559 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 379 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3778 | 0.040 |
Why?
|
| Alleles | 3 | 2018 | 6933 | 0.040 |
Why?
|
| Survival Rate | 1 | 2013 | 12788 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2022 | 565 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 3646 | 0.040 |
Why?
|
| Radiography | 1 | 2010 | 7023 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13286 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2010 | 3476 | 0.040 |
Why?
|
| Biopsy | 1 | 2010 | 6755 | 0.040 |
Why?
|
| Syncope, Vasovagal | 1 | 1997 | 38 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2013 | 12721 | 0.040 |
Why?
|
| Fasting | 2 | 2013 | 1592 | 0.040 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1998 | 277 | 0.040 |
Why?
|
| Linkage Disequilibrium | 2 | 2012 | 1997 | 0.040 |
Why?
|
| Risk Factors | 4 | 2018 | 72296 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 17446 | 0.030 |
Why?
|
| Glucagon | 1 | 2018 | 533 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2018 | 340 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1837 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 57776 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 20952 | 0.030 |
Why?
|
| Haplotypes | 2 | 2012 | 2779 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8664 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39052 | 0.030 |
Why?
|
| Pregnancy | 2 | 2011 | 29144 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2018 | 77460 | 0.030 |
Why?
|
| Potassium, Dietary | 1 | 2012 | 96 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2010 | 21748 | 0.030 |
Why?
|
| Homeostasis | 2 | 2013 | 3339 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2013 | 454 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2022 | 3084 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 513 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1997 | 1403 | 0.020 |
Why?
|
| Exercise Test | 1 | 1997 | 2073 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1997 | 1541 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2011 | 571 | 0.020 |
Why?
|
| Vomiting | 1 | 2011 | 637 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 544 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2010 | 338 | 0.020 |
Why?
|
| Aldosterone | 1 | 2012 | 877 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2022 | 13035 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15078 | 0.020 |
Why?
|
| Genotype | 2 | 2012 | 12952 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 2439 | 0.020 |
Why?
|
| Edema | 1 | 2010 | 789 | 0.020 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2011 | 489 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1889 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 2251 | 0.020 |
Why?
|
| Electrocardiography | 1 | 1997 | 6442 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2010 | 3587 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 26388 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 35425 | 0.010 |
Why?
|
| Lipids | 1 | 2013 | 3307 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8319 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2010 | 1066 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2703 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2018 | 53290 | 0.010 |
Why?
|
| Exercise | 1 | 1997 | 5615 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4328 | 0.010 |
Why?
|
| Prognosis | 2 | 1998 | 29060 | 0.010 |
Why?
|
| Length of Stay | 1 | 2013 | 6311 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10943 | 0.010 |
Why?
|
| Child | 1 | 2007 | 77709 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13409 | 0.010 |
Why?
|
| Macroglossia | 1 | 1998 | 11 | 0.010 |
Why?
|
| DNA | 1 | 2012 | 7294 | 0.010 |
Why?
|
| Ecchymosis | 1 | 1998 | 32 | 0.010 |
Why?
|
| Prednisolone | 1 | 1998 | 334 | 0.010 |
Why?
|
| Colchicine | 1 | 1998 | 244 | 0.010 |
Why?
|
| Young Adult | 2 | 2013 | 56429 | 0.010 |
Why?
|
| Kidney | 1 | 2012 | 7184 | 0.010 |
Why?
|
| Melphalan | 1 | 1998 | 431 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 81201 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1998 | 585 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18034 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15297 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12262 | 0.010 |
Why?
|
| Fatigue | 1 | 1998 | 1531 | 0.010 |
Why?
|
| Animals | 2 | 2012 | 168768 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 12746 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 85779 | 0.000 |
Why?
|
| Echocardiography | 1 | 1998 | 5099 | 0.000 |
Why?
|
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_